Aandeel 6499 MEDEON BIODESIGN, INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Medeon Biodesign, Inc.

Aandelen

6499

TW0006499007

slotkoers Taipei Exchange
Andere beurzen
 00:00:00 26-04-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
42,65 TWD +0,35% Intraday-grafiek van Medeon Biodesign, Inc. +0,83% -8,57%
08/03 Medeon Biodesign, Inc. Rapporteert resultaten voor het gehele jaar geëindigd op 31 december 2023 CI
2023 Medeon Biodesign, Inc. Rapporteert resultaten voor het derde kwartaal en negen maanden eindigend op 30 september 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Medeologix Inc. announced that it expects to receive TWD 315 million in funding from Medeon Biodesign, Inc.
Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Medeon Biodesign, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Medeon Biodesign, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Medeon Biodesign, Inc.(TPEX:6499) added to S&P Global BMI Index
Medeon Biodesign, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Medeon Biodesign, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Medeon Biodesign, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020
Medeon Announces Positive Clinical Results for XFLO Minimally Invasive BPH Treatment Device
Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
Medeon Biodesign, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020
Medeon Biodesign, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020
Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019
Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers 6499
  4. Nieuws Medeon Biodesign, Inc.
  5. Andere talen